Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 140,104Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 68TAKEDA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-1283

Delist Requested :

Patent Use Description : A METHOD OF TREATING C...

Patent Expiration Date : 2026-12-22

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-22

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-1701

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-22

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-836

Delist Requested :

Patent Use Description : A METHOD FOR THE TREAT...

Patent Expiration Date : 2026-12-22

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9493470

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9493470

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1948

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-12

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-1701

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-22

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-22

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9029533

Drug Substance Claim :

Drug Product Claim :

Application Number : 203469

Patent Use Code : U-836

Delist Requested :

Patent Use Description : A METHOD FOR THE TREAT...

Patent Expiration Date : 2026-12-22

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

PONATINIB HYDROCHLORIDE

US Patent Number : 9493470

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203469

Patent Use Code : U-1700

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2033-12-12

blank